LifeSciences British Columbia supports and represents the biopharmaceutical, medical device, bioproducts and bioenergy, and greater life sciences community of British Columbia through leadership, advocacy and promotion of our world-class science and industry. Via active facilitation of partnering and investment into the life sciences sector, British Columbia is fast becoming a global life sciences leader.
Our members include: academic and research institutions; associations; government; and companies from the biopharmaceutical industry, agricultural biotechnology sector, bioinformatics, bioproducts, medical devices, international pharmaceutical multinationals, contract research and scientific services, communications, professional and legal services, human resources, systems and software; and consultants.
British Columbia is the seventh largest biotechnology centre in North America by number of companies, and the fastest growing in Canada. It is home to three of Canada’s largest and most successful biotechnology companies QLT, Angiotech and Aspreva Pharmaceuticals.